Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

614 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of ruxolitinib cream in vitiligo by patient characteristics and affected body areas: Descriptive subgroup analyses from a phase 2, randomized, double-blind trial.
Hamzavi I, Rosmarin D, Harris JE, Pandya AG, Lebwohl M, Gottlieb AB, Butler K, Kuo FI, Sun K, Grimes P. Hamzavi I, et al. Among authors: harris je. J Am Acad Dermatol. 2022 Jun;86(6):1398-1401. doi: 10.1016/j.jaad.2021.05.047. Epub 2021 Jun 2. J Am Acad Dermatol. 2022. PMID: 34089797 Free article. Clinical Trial. No abstract available.
Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus.
Eleftheriadou V, Thomas K, van Geel N, Hamzavi I, Lim H, Suzuki T, Katayama I, Anbar T, Abdallah M, Benzekri L, Gauthier Y, Harris J, Silva de Castro CC, Pandya A, Goh BK, Lan CC, Oiso N, Al Issa A, Esmat S, Le Poole C, Lee AY, Parsad D, Taieb A, Picardo M, Ezzedine K; Vitiligo Global Issues Consensus Group. Eleftheriadou V, et al. Pigment Cell Melanoma Res. 2015 May;28(3):363-9. doi: 10.1111/pcmr.12354. Epub 2015 Feb 13. Pigment Cell Melanoma Res. 2015. PMID: 25645179 No abstract available.
Vitiligo is not a cosmetic disease.
Ezzedine K, Sheth V, Rodrigues M, Eleftheriadou V, Harris JE, Hamzavi IH, Pandya AG; Vitiligo Working Group. Ezzedine K, et al. Among authors: harris je. J Am Acad Dermatol. 2015 Nov;73(5):883-5. doi: 10.1016/j.jaad.2015.07.039. J Am Acad Dermatol. 2015. PMID: 26475548 No abstract available.
Vitiligo.
Picardo M, Dell'Anna ML, Ezzedine K, Hamzavi I, Harris JE, Parsad D, Taieb A. Picardo M, et al. Among authors: harris je. Nat Rev Dis Primers. 2015 Jun 4;1:15011. doi: 10.1038/nrdp.2015.11. Nat Rev Dis Primers. 2015. PMID: 27189851 Review.
Repigmentation in vitiligo: position paper of the Vitiligo Global Issues Consensus Conference.
Gan EY, Eleftheriadou V, Esmat S, Hamzavi I, Passeron T, Böhm M, Anbar T, Goh BK, Lan CE, Lui H, Ramam M, Raboobee N, Katayama I, Suzuki T, Parsad D, Seth V, Lim HW, van Geel N, Mulekar S, Harris J, Wittal R, Benzekri L, Gauthier Y, Kumarasinghe P, Thng ST, Silva de Castro CC, Abdallah M, Vrijman C, Bekkenk M, Seneschal J, Pandya AG, Ezzedine K, Picardo M, Taïeb A; VGICC. Gan EY, et al. Pigment Cell Melanoma Res. 2017 Jan;30(1):28-40. doi: 10.1111/pcmr.12561. Pigment Cell Melanoma Res. 2017. PMID: 27864868
A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo.
Vanderweil SG, Amano S, Ko WC, Richmond JM, Kelley M, Senna MM, Pearson A, Chowdary S, Hartigan C, Barton B, Harris JE. Vanderweil SG, et al. Among authors: harris je. J Am Acad Dermatol. 2017 Jan;76(1):150-151.e3. doi: 10.1016/j.jaad.2016.06.015. J Am Acad Dermatol. 2017. PMID: 27986135 Free PMC article. Clinical Trial. No abstract available.
614 results